electroCore to Participate at Canaccord Genuity MedTech and Diagnostics and Digital Health & Services Forum
Canaccord Genuity MedTech and Diagnostics and
Date:
Event: One-on-one meetings
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.
Investors:
404-736-3838
ecor@cg.capital
